These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38452582)

  • 1. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer.
    Singh S; Saxena S; Sharma H; Paudel KR; Chakraborty A; MacLoughlin R; Oliver BG; Gupta G; Negi P; Singh SK; Dua K
    Pathol Res Pract; 2024 Apr; 256():155222. PubMed ID: 38452582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression and clinical outcome of small cell lung cancer.
    Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
    PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
    Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
    Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
    BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation.
    Stahlhut C; Slack FJ
    Cell Cycle; 2015; 14(13):2171-80. PubMed ID: 25714397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer.
    Zhong S; Golpon H; Zardo P; Borlak J
    Transl Res; 2021 Apr; 230():164-196. PubMed ID: 33253979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
    Li YB; Lin LZ; Guan JS; Chen CM; Zuo Q; Lin BQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep; 36(9):1076-1081. PubMed ID: 30645846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer.
    Liu X; Wang X; Chai B; Wu Z; Gu Z; Zou H; Zhang H; Li Y; Sun Q; Fang W; Ma Z
    Int J Biol Sci; 2022; 18(10):4187-4202. PubMed ID: 35844793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5.
    Li Q; Wang Y; He J
    J Clin Lab Anal; 2021 Jul; 35(7):e23853. PubMed ID: 34057242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.
    Mizuno K; Mataki H; Arai T; Okato A; Kamikawaji K; Kumamoto T; Hiraki T; Hatanaka K; Inoue H; Seki N
    J Hum Genet; 2017 Jul; 62(7):671-678. PubMed ID: 28275243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.
    Naidu S; Shi L; Magee P; Middleton JD; Laganá A; Sahoo S; Leong HS; Galvin M; Frese K; Dive C; Guzzardo V; Fassan M; Garofalo M
    Sci Rep; 2017 Nov; 7(1):15441. PubMed ID: 29133857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
    Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
    Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
    Tanigawa K; Misono S; Mizuno K; Asai S; Suetsugu T; Uchida A; Kawano M; Inoue H; Seki N
    Mol Oncol; 2023 Feb; 17(2):328-343. PubMed ID: 36345848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Role of MiR-140-5p for the Treatment of Non-small Cell Lung Cancer.
    Flamini V; Jiang WG; Cui Y
    Anticancer Res; 2017 Aug; 37(8):4319-4327. PubMed ID: 28739724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.